Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Poston

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management|October 24, 2012
Adherence to 5-alpha reductase inhibitor therapy for benign prostatic hyperplasia: clinical and economic outcomesStephen Gruschkus, Sara Poston, Michael Eaddy, et al.
Pharmacoeconomics - Open|April 16, 2021
State-Level Variations and Factors Associated with Adult Vaccination Coverage: A Multilevel Modeling ApproachDiana Garbinsky, Shannon Hunter, Elizabeth M La, et al.
Journal of the American Pharmacists Association : Japha|November 12, 2021
The impact of community pharmacy utilization of immunization information systems on vaccination rates: Results of a clustered randomized controlled trialPamela C Heaton, Brandy Altstadter, Cosmina Hogea, et al.
Vaccine|February 27, 2025
Corrigendum to "The potential impact of increased recombinant zoster vaccine coverage on the burden of herpes zoster among adults aged 50-59 years" [Vaccine 41 (37) (23 August 2023) 5360-5367]David Singer, Ahmed Salem, Nikita Stempniewicz, et al.
Vaccine|August 4, 2023
The potential impact of increased recombinant zoster vaccine coverage on the burden of herpes zoster among adults aged 50-59 yearsDavid Singer, Ahmed Salem, Nikita Stempniewicz, et al.
Population Health Management|June 5, 2024
Knowledge, Attitudes, and Practices Regarding Herpes Zoster Vaccination Among SpecialistsDavid Singer, Carolyn Sweeney, Nikita Stempniewicz, et al.
Vaccine|March 3, 2020
The adult vaccination landscape in the United States during the Affordable Care Act era: Results from a large retrospective database analysisEmmanuel Aris, Marion Montourcy, Elizabeth Esterberg, et al.
Human Vaccines & Immunotherapeutics|January 20, 2022
Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United StatesDesmond Curran, Elizabeth M La, Ahmed Salem, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|September 14, 2021
National and State-Level Composite Completion of Recommended Vaccines Among Adolescents in the United States, 2015-2018Elizabeth M La, Diana Garbinsky, Shannon Hunter, et al.
Vaccine|April 14, 2021
Meningococcal B vaccination coverage among older adolescents in the United StatesElizabeth M La, Diana Garbinsky, Shannon Hunter, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
P & T : a Peer-Reviewed Journal for Formulary Management|October 24, 2012
Adherence to 5-alpha reductase inhibitor therapy for benign prostatic hyperplasia: clinical and economic outcomesStephen Gruschkus, Sara Poston, Michael Eaddy, et al.
Pharmacoeconomics - Open|April 16, 2021
State-Level Variations and Factors Associated with Adult Vaccination Coverage: A Multilevel Modeling ApproachDiana Garbinsky, Shannon Hunter, Elizabeth M La, et al.
Journal of the American Pharmacists Association : Japha|November 12, 2021
The impact of community pharmacy utilization of immunization information systems on vaccination rates: Results of a clustered randomized controlled trialPamela C Heaton, Brandy Altstadter, Cosmina Hogea, et al.
Vaccine|February 27, 2025
Corrigendum to "The potential impact of increased recombinant zoster vaccine coverage on the burden of herpes zoster among adults aged 50-59 years" [Vaccine 41 (37) (23 August 2023) 5360-5367]David Singer, Ahmed Salem, Nikita Stempniewicz, et al.
Vaccine|August 4, 2023
The potential impact of increased recombinant zoster vaccine coverage on the burden of herpes zoster among adults aged 50-59 yearsDavid Singer, Ahmed Salem, Nikita Stempniewicz, et al.
Population Health Management|June 5, 2024
Knowledge, Attitudes, and Practices Regarding Herpes Zoster Vaccination Among SpecialistsDavid Singer, Carolyn Sweeney, Nikita Stempniewicz, et al.
Vaccine|March 3, 2020
The adult vaccination landscape in the United States during the Affordable Care Act era: Results from a large retrospective database analysisEmmanuel Aris, Marion Montourcy, Elizabeth Esterberg, et al.
Human Vaccines & Immunotherapeutics|January 20, 2022
Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United StatesDesmond Curran, Elizabeth M La, Ahmed Salem, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|September 14, 2021
National and State-Level Composite Completion of Recommended Vaccines Among Adolescents in the United States, 2015-2018Elizabeth M La, Diana Garbinsky, Shannon Hunter, et al.
Vaccine|April 14, 2021
Meningococcal B vaccination coverage among older adolescents in the United StatesElizabeth M La, Diana Garbinsky, Shannon Hunter, et al.
Pageof 3